Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers.

about

Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake Conditions.Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjects.

P2860

Q50711101-8F74E743-F641-4615-ACF3-E787ABF610BA Q55060584-FFA8A3F4-8DDD-4BA6-82E0-8915C084B954

P2860

Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers.

Item

http://www.wikidata.org/entity/Q53357202

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Effects of famotidine or an an ...... lotinib in healthy volunteers.

@en

Effects of famotidine or an an ...... lotinib in healthy volunteers.

@nl

type

Item

label

Effects of famotidine or an an ...... lotinib in healthy volunteers.

@en

Effects of famotidine or an an ...... lotinib in healthy volunteers.

@nl

prefLabel

Effects of famotidine or an an ...... lotinib in healthy volunteers.

@en

Effects of famotidine or an an ...... lotinib in healthy volunteers.

@nl

P1476

Effects of famotidine or an an ...... lotinib in healthy volunteers.

@en

P2093

Azra Hussaini

http://www.w3.org/2001/XMLSchema#string

Cheng Zheng

http://www.w3.org/2001/XMLSchema#string

Ophelia Q P Yin

http://www.w3.org/2001/XMLSchema#string

Steven Novick

http://www.w3.org/2001/XMLSchema#string

Tracey McCulloch

http://www.w3.org/2001/XMLSchema#string

Véronique Bédoucha

http://www.w3.org/2001/XMLSchema#string

Wei Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL

Tasigna for chronic and accelerated phase Philadelphia chromosome--positive chronic myelogenous leukemia resistant to or intolerant of imatinib.

Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.

Review article: drug interactions with agents used to treat acid-related diseases.

Acid suppressive therapy use on an inpatient internal medicine service.

Systematic review: impaired drug absorption related to the co-administration of antisecretory therapy.

Should the concomitant use of erlotinib and acid-reducing agents be avoided? The drug interaction between erlotinib and acid-reducing agents.

Clinically significant drug interactions with antacids: an update.

Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase.

Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.

P2888

s00280-012-1999-3

P304

219-226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-012-1999-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23070146

http://www.w3.org/2001/XMLSchema#string

Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers.

about

P2860

P2860

Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698